Biggest News Aggregation in the World
📰 Biodirection Inc News

Biodirection Inc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Biodirection Inc. Real-time updates on events, politics, business and more.

Global Traumatic Brain Injuries Assessment Market Expected to Garner $18,373.6 Million by 2031, Growing at 7.0% CAGR from 2022-2031 [250-Pages]

The traumatic brain injuries assessment market is expected to grow by 2031 due to increasing cases of brain injuries. The hospitals sub-segment is predicted to be highly lucrative. The market
New York United States Integra Lifesciences Abhishek Paliwal Kostenloser Wertpapierhandel Koninklijke Philips

Global Sepsis Diagnostics Markets Report 2022: Some Players have Already Made their Mark but Disruptive Diagnostic Technology Could Change the Field of Play

DUBLIN, Jan. 19, 2022 The "Sepsis Diagnostics - Global Markets by Assay, by Cause, by Product, by Lab, and by Place, with Executive and Consultant Guides and...
Siemens Healthineers Qiagen Gmbh Laura Wood Profiles Of Key Companies Academic Research Lab Clearance For Blood Panel

Global Sepsis Diagnostics Markets Report 2021: Rapid Diagnositics and the Genomics Revolution are Merging to Create New Diagnostic Opportunities

5.3.3 Diagnostics Moves Out of the Lab 5.3.4 Biomarkers and Algorithms 5.3.6 Genome Role and Big Data 5.3.7 The Next Five Years 6 Sepsis Diagnostics - Recent Developments 6.1 Recent Developments - Importance and How to Use This Section 6.1.1 Importance of These Developments 6.1.2 How to Use This Section 6.2 Study Establishes Cytovale IntelliSep Test for Rapid Diagnosis of Sepsis 6.3 Baebies Awarded $11.6M to Develop Diagnostic Platform to ID Sepsis 6.4 Personalized Medicine in Sepsis 6.5 Point-...
United States Siemens Healthineers Qiagen Gmbh Biomarker Mdx Laura Wood Profiles Of Key Companies

Worldwide Industry for Sepsis Diagnostics to 2025 - Featuring Abbott Diagnostics, Abionic and Beckman Coulter Among Others

Share this article Share this article ResearchAndMarkets.coms offering. Sepsis was killing over 30 million people a year with no definitive diagnostic in hand. And now the COVID-19 Pandemic has increased the sepsis death toll. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life-saving diagnostics can command a premium in the market, especiall...
Siemens Healthineers Qiagen Gmbh Biomarker Mdx Laura Wood Profiles Of Key Companies Academic Research Lab

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science